The Canton of Solothurn had a valuation report prepared for its hospitals
February 2025 — The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.
As part of its audit work, the Solothurn Cantonal Audit Office, as external auditors, had a second opinion prepared, which answers various questions in connection with soH’s annual impairment test and other valuation questions.
Our role in the transaction
The Oaklins team in Switzerland was able to draw on its longstanding experience and profound expertise in valuation topics for this challenging assignment. It conducted the relevant valuation analyses, interviewed management and external stakeholders and answered and documented the specific questions in a comprehensive report.
Gabrielle Rudolf von Rohr
Head of the Cantonal Audit Office, Solothurn
Prata med transaktionsteamet
Relaterade transaktioner
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Lär dig merAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Lär dig merLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Lär dig mer